|
Number of patients
|
187
|
61
| |
|
Age (years)
|
65.7 ± 12.1
|
73.7 ± 9.8
|
P < 0.01
|
|
Gender (m/f)
|
102/85
|
35/26
|
NS
|
|
Body mass index (kg/m2)
|
22.5 ± 3.6
|
20.9 ± 3.5
|
P < 0.01
|
|
Dialysis history (months)
|
64.9 ± 55.7
|
61.0 ± 57.2
|
NS
|
|
Diabetes (%)
|
80 (43)
|
41 (67)
|
P < 0.01
|
|
Hyperlipidemia drugs (%)
|
22 (12)
|
12 (20)
|
NS
|
|
Systolic BP (mmHg)
|
152 ± 20
|
150 ± 26
|
NS
|
|
Diastolic BP (mmHg)
|
77 ± 14
|
73 ± 14
|
NS
|
|
Laboratory study
|
|
Hemoglobin (g/dl)
|
10.8 ± 0.9
|
10.9 ± 1.0
|
NS
|
|
High-density lipoprotein cholesterol (mg/dl)
|
47.9 ± 15.3
|
43.9 ± 12.7
|
NS
|
|
Low-density lipoprotein cholesterol (mg/dl)
|
87.5 ± 29.2
|
91.6 ± 30.2
|
NS
|
|
Triglyceride (mg/dl)
|
100 ± 58
|
114 ± 87
|
NS
|
|
Uric acid (mg/dl)
|
7.2 ± 1.4
|
7.0 ± 1.3
|
NS
|
|
Creatinine (mg/dl)
|
9.9 ± 2.6
|
8.6 ± 2.1
|
P < 0.01
|
|
C-reactive protein (mg/dl)
|
0.3 ± 0.7
|
0.5 ± 0.8
|
NS
|
|
Ca (mg/dl)
|
8.9 ± 0.5
|
8.9 ± 0.5
|
NS
|
|
Inorganic phosphorus (mg/dl)
|
5.2 ± 1.1
|
5.1 ± 1.0
|
NS
|
|
Intact-parathyroid hormone (pg/ml)
|
139 ± 80
|
151 ± 96
|
NS
|
|
Albumin (g/dl)
|
3.7 ± 0.3
|
3.5 ± 0.4
|
P < 0.01
|
|
Hemoglobin A1c (%)
|
5.3 ± 0.8
|
5.5 ± 1.0
|
NS
|
|
Human atrial natriuretic polypeptide (pg/ml)
|
60 ± 55
|
103 ± 197
|
P < 0.01
|
|
Brain natriuretic peptide (pg/ml)
|
216 ± 241
|
429 ± 693
|
P < 0.01
|
|
Cardiothoracic ratio (%)
|
51.7 ± 4.7
|
54.8 ± 6.3
|
P < 0.01
|
|
Brachial-ankle pulse wave velocity (cm/s)
|
1971 ± 540
|
2317 ± 894
|
P < 0.01
|
|
Abdominal circumference (cm)
|
84.4 ± 10.3
|
80.6 ± 10.1
|
P < 0.05
|
|
Visceral fat area (cm2)
|
89.8 ± 62.1
|
69.2 ± 49.7
|
P < 0.05
|
|
Subcutaneous fat area (cm2)
|
124.8 ± 71.3
|
97.6 ± 76.3
|
P < 0.05
|
